Roivant Sciences (ROIV) Amortizatization of Intangibles (2024 - 2025)

Roivant Sciences (ROIV) posted Amortizatization of Intangibles of $29.6 million for Q4 2025, up 201.43% on a QoQ basis from $9.8 million in Q3 2025, and down 45.48% year-over-year from $54.3 million in Q4 2024.

Roivant Sciences (ROIV) Amortizatization of Intangibles (2024 - 2025) Analysis & Trends

Roivant Sciences' Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $29.6 million for Q4 2025.

  • Quarterly Amortizatization of Intangibles fell 45.48% year-over-year to $29.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $104.8 million (up 32.08% YoY) and the FY2025 annual result came in at $70.0 million, changed N/A from the prior year.
  • Amortizatization of Intangibles was $29.6 million for Q4 2025 at Roivant Sciences, up from $9.8 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $54.3 million in Q4 2024 and bottomed at $9.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 3.22 Mn
10 Roivant Sciences 24.16 Bn 24.16 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 29.61 Mn
Dec 31, 2025 29.61 Mn
Sep 30, 2025 9.82 Mn
Sep 30, 2025 9.82 Mn
Jun 30, 2025 11.06 Mn
Jun 30, 2025 11.06 Mn
Dec 31, 2024 54.30 Mn
Dec 31, 2024 54.30 Mn
Sep 30, 2024 25.04 Mn
Sep 30, 2024 25.04 Mn